Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Opsoclonus myoclonus with ataxia].

Ilan Asher1, Daniel Elbirt, M Kushnir

  • 1Department of Internal Medicine B, Kaplan Medical Center Rehovot affiliated to the Hadassah Hebrew University Medical School, Jerusalem, Israel.

Harefuah
|April 23, 2005
PubMed
Summary

Paraneoplastic opsoclonus myoclonus with ataxia (POMA) is a rare neurological disorder linked to cancer and autoantibodies. Diagnosis and treatment of POMA remain challenging, as illustrated by this case study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monthly oral pre-exposure prophylaxis and the importance of tissue pharmacokinetics: lessons from islatravir.

AIDS (London, England)·2026
Same author

Low-normal immunoglobulin suggests monoclonal B-cell lymphocytosis and constitutional CLL susceptibility: a dual-mechanism analysis.

Leukemia·2026
Same author

[Immunotherapy for Inhalant Allergy - Long Term Efficacy].

Harefuah·2026
Same author

Isolated ventricular septal defect is not a risk factor for celiac disease: evidence from a large real-world data cohort of 493,382 children.

Frontiers in pediatrics·2026
Same author

Low serum IgE is associated with an increased risk of chronic lymphocytic leukemia: a large retrospective cohort study.

Frontiers in immunology·2026
Same author

Severe eosinophilia and risk of major disease and mortality: A nationwide cohort study of children and adults.

The journal of allergy and clinical immunology. Global·2026

Area of Science:

  • Neurology
  • Immunology
  • Oncology

Background:

  • Opsoclonus myoclonus with ataxia (OMA) is a rare neurological disorder with diverse etiologies.
  • Paraneoplastic opsoclonus myoclonus with ataxia (POMA) is associated with various cancers, particularly in adults over 40.
  • The pathogenesis is believed to involve autoantibodies targeting onconeural antigens shared by tumors and neurons.

Purpose of the Study:

  • To present a case study of POMA.
  • To highlight the diagnostic and therapeutic challenges associated with POMA.

Main Methods:

  • Case report detailing clinical presentation, diagnosis, and treatment of a POMA patient.
  • Review of literature on OMA and POMA etiologies, pathogenesis, and treatment outcomes.

Related Experiment Videos

Main Results:

  • The case illustrates the complexities in diagnosing and managing POMA.
  • Treatment outcomes for POMA are often disappointing despite aggressive immunosuppressive therapies.

Conclusions:

  • OMA is a rare but serious neurological condition with paraneoplastic origins.
  • Effective diagnostic and treatment strategies for POMA are still needed.